← All stocks

Adaptive Biotechnologies Corp

ADPT Net selling

CIK 0001478320 #1515 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$118.67M

$32.46M on a plan · $70.75M straight out of an exercise

Sold at will

$15.46M

13 of 125 sales

Net

−$118.67M

−$15.46M against sales at will

By person

12 insiders · 125 transactions

81.1×

Chad Robins holds 81.1 times base salary in stock. $56.69M of shares against $698.26K in salary for 2025.

Salary from the company's own proxy. The shares are what Chad Robins last reported holding, valued at $26.00, the price Common Stock was last bought or sold at on the open market here, on 26 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ROBINS CHAD M

CEO and Chairman

—

$39.80M (19) scheduled

−$39.80M

2,180,518

1.37%

$56.69M

−15.4%

ROBINS HARLAN S

Chief Scientific Officer

—

$29.65M (17) scheduled

−$29.65M

812,058

0.5088%

$21.11M

−20.5%

BENZENO SHARON

Chief Commercial Ofc Imm Med

—

$14.69M (6) scheduled

−$14.69M

221,278

0.1386%

$5.75M

−32.4%

RUBINSTEIN JULIE

President and COO

—

$13.37M (47) scheduled

−$13.37M

377,802

0.2367%

$9.82M

−20.1%

LO FRANCIS

Chief People Officer

—

$9.90M (12) scheduled

−$9.90M

230,713

0.1446%

$6.00M

−9.1%

PISKEL KYLE

Chief Financial Officer

—

$3.58M (6) scheduled

−$3.58M

256,725

0.1609%

$6.67M

+74.9%

NEUPERT PETER M

Director

—

$3.14M (3) scheduled

−$3.14M

130,625

0.0818%

$3.40M

−22.8%

GRIFFIN MICHELLE RENEE

Director

—

$2.00M (3) scheduled

−$2.00M

15,625

0.0098%

$406.25K

−69.9%

BOBULSKY SUSAN

Chief Commercial Officer, MRD

—

$1.17M (8) scheduled

−$1.17M

396,989

0.2487%

$10.32M

+59.9%

HERSHBERG ROBERT

Director

—

$1.12M (3) scheduled

−$1.12M

46,683

0.0293%

$1.21M

−56.5%

OWEN KATEY EINTERZ

Director

—

$249.99K (1)

−$249.99K

66,100

0.0414%

$1.72M

+15.5%

Pellini Michael J

Director

—

69,690

0.0437%

$1.81M

+28.4%

Adaptive Biotechnologies Corp

By person

Individual transactions

What was left out